Abingdon and Birmingham Uni set up Dx joint venture
This article was originally published in Clinica
Diagnostics specialist Abingdon Health has teamed up with the UK’s University of Birmingham to launch a new company, Bioscience Ventures. The joint venture will develop diagnostic products, based on intellectual property originating from the university, in areas such as cancer, genetic diseases, infectious diseases, drug testing and veterinary applications. Bioscience, which will be based at the university's campus in Edgbaston and trade through its subsidiary company Alta Bioscience, will also provide a variety of services such as analysis and synthesis of DNA, protein and other biochemicals to clients both on and off campus in the pharmaceutical and food industries.